Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04171960 · ClinicalTrials.gov registry record
Clinical Evaluation of the i-STAT TBI Test
A clinical trial, sponsored by Abbott Point of Care.
- Completed
- Registry status
- 1,106
- Enrollment target
NCT04171960 is a clinical trial that has completed, run by Abbott Point of Care. The registered enrollment target is 1,106 participants.
The verdict
NCT04171960 has completed, sponsored by Abbott Point of Care.
- COMPLETED
- Registry status
- 1,106 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate the i-STAT TBI test to assist determining the need for a computed tomography (CT) scan in patients with suspected mild traumatic brain injury (TBI). Patients will be asked to provide a blood sample.
Interventions
- DIAGNOSTIC_TEST Blood draw
- OTHER Outcome assessments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,106 participants |
| Start Date | 2020-07-31 |
| Est. Completion | 2023-11-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04171960
The ClinicalTrials.gov registry entry for NCT04171960 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Point of Care, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood draw is the first listed.
NCT04171960 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04171960 about?
NCT04171960 is a clinical study titled "Clinical Evaluation of the i-STAT TBI Test". The goal of this study is to evaluate the i-STAT TBI test to assist determining the need for a computed tomography (CT) scan in patients with suspected mild traumatic brain injury (TBI). Patients will be asked to provide a blood sample.
What is the current status of trial NCT04171960?
This trial is currently completed. The enrollment target is 1,106 participants. The study started on 2020-07-31. Estimated completion is 2023-11-29.
What interventions are being tested in trial NCT04171960?
The interventions under investigation include: Blood draw (DIAGNOSTIC_TEST), Outcome assessments (OTHER).
Who is sponsoring clinical trial NCT04171960?
This trial is sponsored by Abbott Point of Care, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.